Compare Klinko Karya Imaji Tbk. (KLIN) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Klinko Karya Imaji Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Klinko Karya Imaji Tbk. trades at Rp125 (market cap 166.06B, 652.9K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Klinko Karya Imaji Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| KLIN | SCPI | |
|---|---|---|
Market Cap | 166.06B | 104.4B |
Volume | 652.9K | — |
Lot | 6.53K | — |
Turnover | 79.82M | — |
Average Price | 122.25 | — |
Value | 79.82M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Klinko Karya Imaji Tbk.
PT Klinko Karya Imaji Tbk (the Company) was established on November 4, 2016 based on Notarial Deed No. 3 by Ribka Avie Alreta, S.H., M.Kn. The Company started its commercial operations in 2017.
Read more on KLIN →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
